Clinical trial
Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes
NCT00276393 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00276393 |
|---|---|
| Title | Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes |
| Official title | Randomized Trial Comparing Insulin Glargine to Ultra-Lente Insulin in Type I Diabetes |
| Lead sponsor | Mayo Clinic, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | Basal insulin |
| Enrollment | 22 |
| Start date | Jul 1, 2002 |
| Primary completion | Dec 1, 2003 |
| Completion | Dec 1, 2003 |
| First posted | Jan 13, 2006 |
| Last update posted | May 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: